PREFORMED LINE PRODUCTS CO
For the period ended Dec 31, 2025. Filed Mar 5, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 5, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
(a)Report of Independent Registered Public Accounting Firm (PCAOB ID: 0042)
Financial Statements and Schedule
| Page | Financial Statements |
| 30 | Consolidated Balance Sheets |
| 31 | Statements of Consolidated Income |
| 32 | Statements of Consolidated Comprehensive Income |
| 33 | Statements of Consolidated Cash Flows |
| 34 | Statements of Consolidated Shareholders’ Equity |
| 35 | Notes to Consolidated Financial Statements |
| Page | Schedule |
| 69 | II - Valuation and Qualifying Accounts |
(b)Exhibits
| ExhibitNumber | Exhibit |
| 3.1 | Amended and Restated Articles of Incorporation (incorporated by reference to the Company’s Registration Statement on Form 10). |
| 3.2 | Amended and Restated Code of Regulations of Preformed Line Products Company (incorporated by reference to the Company’s Registration Statement on Form 10). |
| 3.3 | Amendment to the Amended and Restated Code of Regulations of Preformed Line Products Company, effective May 10, 2016 (incorporated by reference to the Company's Registration Statement on Form 10). |
| 4.1 | Description of Specimen Share Certificate (incorporated by reference to the Company’s Registration Statement on Form 10). |
| 4.2 | Description of the Registrant’s Securities Registered Under Section 12 of the Securities Exchange Act of 1934 (incorporated by reference to the Company’s 10-K filed for the year ended December 31, 2019). |
| 10.1 | Preformed Line Products Company Executive Life Insurance Plan – Summary (incorporated by reference to the Company’s Registration Statement on Form 10).* |
| 10.2 | Preformed Line Products Company Supplemental Profit Sharing Plan (incorporated by reference to the Company’s Registration Statement on Form 10).* |
| 10.3 | Preformed Line Products Company 2016 Incentive Plan (incorporated by reference to the Company's 10-K filing for the year ended December 31, 2020).* |
| 10.4 | Preformed Line Products Company 2016 RSU Award Agreement, filed herewith * |
| 10.5 | Preformed Line Products Company 2016 Stock Option Award Agreement, filed herewith * |
| 10.6 | Preformed Line Products Company 2025 Incentive Plan, filed herewith * |
| 10.7 | Preformed Line Products Company 2025 RSU Award Agreement, filed herewith * |
| 10.8 | Preformed Line Products Company 2025 Stock Option Award Agreement, filed herewith * |
| 10.9 | Deferred Shares Plan (incorporated by reference to the Company’s 8-K current report filing dated August 21, 2008).* |
| 10.10 | Promissory Note dated June 27, 2016, between the Company and PNC Bank, National Association (incorporated by reference to the Company’s Form 10-Q filing for the quarter ended June 30, 2016). |
| 10.11 | Amended and Restated Loan Agreement dated September 24, 2015 between the Company and PNC Bank, National Association (incorporated by reference to the Company’s 10-K filing for the year ended December 31, 2015). |
| 10.12 | Amendment No. 1 to Amended and Restated Loan Agreement dated November 6, 2015 between the Company and PNC Bank, National Association (incorporated by reference to the Company’s 10-K filing for the year ended December 31, 2015). |
| 10.13 | Amendment No. 2 to Amended and Restated Loan Agreement dated August 22, 2016 between the Company and PNC Bank, National Association (incorporated by reference to the Company’s Form 10-Q filing for the quarter ended September 30, 2016). |
| 10.14 | Joinder and Amendment No. 3 to Amended and Restated Loan Agreement dated March 13, 2018 between the Company and PNC Bank, National Association (incorporated by reference to the Company’s Form 10-Q filing for the quarter ended March 31, 2018). |
| 10.15 | Joinder and Amendment No. 5 to Amended and Restated Loan Agreement dated April 25, 2019 between the Company and PNC Bank, National Association (incorporated by reference to the Company’s 10-Q filing for the quarter ended March 31, 2019). |
| 10.16 | Promissory Note dated December 29, 2020, and Other Loan Documents between the Company and PNC Bank National Association, filed herewith. |
| 10.17 | Amendment No. 7 to Amended and Restated Loan Agreement, dated March 2, 2022, between the Company and PNC Bank, National Association Joinder, (incorporated by reference to the Company's 10-K filing for the year ended December 31, 2021). |
| 10.18 | Joinder and Amendment No. 8 to Amended and Restated Loan Agreement dated March 14, 2025, as amended, between the Company and PNC Bank, National Association previously filed as Exhibit 10.1 to Form 10-Q for the quarter ended March 31, 2025 and incorporated by reference herein. |
| 10.19 | Fifteenth Amended and Restated Line of Credit Note, dated July 30, 2025, between the Company and PNC Bank, National Association previously filed as Exhibit 10.2 to the Form 10-Q for the quarter ended June 30, 2025 and incorporated by reference herein. |
| 10.20 | Amendment No. 9 to Amended and Restated Loan Agreement dated July 30, 2025, as amended, between the Company and PNC Bank, National Association previously filed as Exhibit 10.1 to the Form 10-Q for the quarter ended June 30, 2025 and incorporated by reference herein. |
| 10.21 | Investment Loan Agreement, dated July 16, 2025, between PLP Poland (Belos) S.A. and Bank Pekao S.A., (English translation) previously filed as Exhibit 10.1 to Form 8-K (File No. 0-31164), filed on July 22, 2025 and incorporated herein by reference ). |
| 14.1 | Preformed Line Products Amended Company Code of Conduct (incorporated by reference to the Company’s 10-K filed for the year ended December 31, 2019) |
| 19 | Preformed Line Products Company Insider Trading Policy as of February 13, 2025 (incorporated by reference to the Company’s 10-K filed for the year ended December 31, 2024) |
| 21 | Subsidiaries of Preformed Line Products Company, filed herewith. |
| 23.1 | Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm, filed herewith. |
| 31.1 | Certification of the Principal Executive Officer, Robert G. Ruhlman, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. |
| 31.2 | Certification of the Principal Accounting Officer, Andrew S. Klaus, pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, filed herewith. |
| 32.1 | Certification of the Principal Executive Officer, Robert G. Ruhlman, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, furnished. |
| 32.2 | Certification of the Principal Accounting Officer, Andrew S. Klaus, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, furnished. |
| 97.1 | Preformed Line Products Company Clawback Policy adopted on August 2, 2023 (incorporated by reference to the Company's 10-K filed for the year ended December 31, 2023). |
| 101.INS | Inline XBRL Instance Document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 104 | Cover Page Interactive Data File (embedded within the inline XBRL document) |
*Indicates management contracts or compensatory plan or arrangement.
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized.
| Preformed Line Products Company | |
| March 5, 2026 | /s/ Robert G. Ruhlman |
|---|---|
| Robert G. Ruhlman | |
| Executive Chairman | |
| (principal executive officer) | |
| March 5, 2026 | /s/ Andrew S. Klaus |
| Andrew S. Klaus | |
| Chief Financial Officer | |
| (principal financial and accounting officer) |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacity and on the dates indicated.
| March 5, 2026 | /s/ Robert G. Ruhlman |
|---|---|
| Robert G. Ruhlman | |
| Executive Chairman | |
| March 5, 2026 | * |
| Glenn E. Corlett | |
| Director | |
| March 5, 2026 | * |
| Matthew D. Frymier | |
| Director | |
| March 5, 2026 | * |
| R. Steven Kestner | |
| Director | |
| March 5, 2026 | * |
| Richard R. Gascoigne | |
| Director | |
| March 5, 2026 | * |
| J. Ryan Ruhlman | |
| Director | |
| March 5, 2026 | * |
| Maegan A. R. Cross | |
| Director | |
| March 5, 2026 | * |
| David C. Sunkle | |
| Director | |
| *By Power of Attorney | |
| March 5, 2026 | /s/ Caroline S. Vaccariello |
| Caroline S. Vaccariello | |
| General Counsel and Corporate Secretary |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.